The global smart insulin or glucose responsive insulin market size was valued at $2,773.73 million in 2019, and is expected to reach $6,174.30 million by 2027, registering a CAGR of 10.5% from 2020 to 2027.
The global continuous glucose monitoring systems (CGMS) market size was valued at $1,774.2 million in 2019, and is projected to reach $8,844.9 million by 2027, registering a CAGR of 22.0% during the forecast period.
Insulin a glucose directing hormone, is an essential part of the treatment plan for many patients with advanced type 2 diabetes mellitus (T2DM) and patients with T1DM. Insulin facilitates the diversion of ...
Insulin occurs in nature and is used for lowering glucose hormones by many diabetic people for the regulation of blood sugar. People who suffer from type 1 diabetes are compensated by supplementary ...
Are you not able to find what exactly you are looking for?
There might be something that we haven’t covered in the scope and if it is as per your specific areas of interest, we can anytime customise and incorporate your requirements in the framework of the study and provide you with a customised report based on your exact needs.
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.